HomeArticlesGlioblastoma (GBM: Ring-Enhancement, Central Necrosis, Diffusion Restriction & Cross-Midline Spread)
NeuroradiologyHigh-Yield ReferenceHigh-Yield Clinical & Imaging Reference

Glioblastoma (GBM: Ring-Enhancement, Central Necrosis, Diffusion Restriction & Cross-Midline Spread)

  • Seen in older adults (55–75 years, male predominance) presenting subacutely with progressive headaches, cognitive decline, personality changes, new focal neurological deficits, or adult-onset seizures.
  • Caused by WHO Grade 4 diffuse astrocytic glioma characterized by IDH-wildtype status, microvascular proliferation, and/or pseudopalisading necrosis; highly aggressive, infiltrative malignant neoplasm with dismal prognosis.

Imaging Findings

  • Multiparametric Brain MRI (Diagnostic Standard):
  • –
    Thick, Irregular, Nodular Peripheral Ring Enhancement: Markedly heterogeneous peripheral rim enhancement surrounding a non-enhancing, necrotic and cystic core.
  • –
    Central Necrosis: Markedly hyperintense on T2WI and hypointense on T1WI, typically showing facilitated diffusion centrally (ADC high) due to liquefactive necrosis.
  • –
    Restricted Diffusion in Solid Rim: Hypercellular peripheral viable tumor rim demonstrates hyperintensity on DWI and corresponding low ADC values.
  • –
    Extensive Infiltrative Vasogenic Edema: Striking T2/FLAIR hyperintensity tracking along white matter tracts; tumor cells invariably infiltrate extensively into the non-enhancing FLAIR signal abnormality.
  • –
    Cross-Midline Extension ('Butterfly Glioma'): Direct transcallosal infiltration through the genu or splenium of corpus callosum into contralateral hemisphere.
  • –
    DWI / ADC: The thick, hypercellular enhancing peripheral rim shows diffusion restriction (high DWI, low ADC), whereas the central necrotic core shows facilitated diffusion (low DWI, high ADC)—the exact opposite of a pyogenic cerebral abscess.
  • –
    **SWI / T2* GRE: Prominent irregular blooming artifact and intratumoral susceptibility signals (ITSS)** along the necrotic rim due to microvascular proliferation, neoangiogenesis, and intratumoral microhemorrhages.
  • MR Perfusion & Spectroscopy (Physiological Signatures):
  • –
    DSC Perfusion: Marked elevation of relative Cerebral Blood Volume (rCBV >2.5–3.0) in the enhancing rim and surrounding infiltrating edema (neoangiogenesis).
  • –
    MR Spectroscopy (MRS): High Choline (Choline/Creatine ratio >2.0), profoundly depressed or absent NAA, and elevated lipid-lactate double peak at 1.33 ppm.

Differential Diagnosis

Glioblastoma (GBM: Ring-Enhancement, Central Necrosis, Diffusion Restriction & Cross-Midline Spread) Differential Diagnosis Comparison Table — How Other Conditions Differ on CT, MRI, Ultrasound, and X-Ray
Differential DiagnosisKey Distinguishing Features
Cerebral Abscess
Smooth, thin, uniform enhancing ring ('smooth inner margin'); non-enhancing dependent rim is hypointense on T2 (capsule); central liquefied pus demonstrates intense, uniform restricted diffusion (bright DWI, dark ADC); prominent surrounding edema.
Solitary Brain Metastasis
Well-circumscribed, spherical enhancing lesion situated at the gray-white matter junction with disproportionate surrounding vasogenic edema; perfusion (rCBV) is elevated in the tumor rim but completely normal in the surrounding peritumoral edema (pure vasogenic edema, lacks infiltrative tumor cells).
Tumefactive Demyelinating Lesion (TDL)
Open-ring or 'horseshoe' enhancement with the non-enhancing opening directed toward the cortical gray matter; less mass effect/edema relative to size; restricted diffusion along the leading advancing rim.
Primary CNS Lymphoma (PCNSL)
In immunocompetent patients, densely homogeneous enhancing periventricular/subependymal mass with intense restricted diffusion (high cellularity, low ADC); lacks central necrosis; dramatic shrinkage following corticosteroids.

Important Points to Remember

  • Diagnostic Pitfall: Reporting peritumoral T2/FLAIR hyperintensity as 'pure vasogenic edema'! In glioblastoma, the surrounding FLAIR hyperintensity represents non-enhancing infiltrating tumor cells mixed with vasogenic edema. MR perfusion (DSC-rCBV) in this region shows elevated perfusion, distinguishing it from pure vasogenic edema surrounding brain metastases.
  • Crucial Review Areas:
  • 1.
    Corpus callosum (genu and splenium) for subtle transcallosal crossing ('butterfly glioma').
  • 2.
    Subependymal ventricular lining for nodular enhancement (ventricular dissemination carries worse staging and precludes gross total resection).
  • 3.
    Leptomeninges and distant brain parenchyma for multifocal or multicentric disease.
  • 4.
    Internal carotid / middle cerebral artery branches for vascular encasement.
  • Case-Specific Radiologist Management:
  • 1.
    Immediate Verbal Alert: Direct telephone notification to on-call neurosurgical registrar for acute significant midline shift (>5 mm), impending subfalcine or transtentorial herniation, or acute hydrocephalus.
  • 2.
    Avoid Pre-Biopsy Steroids if Lymphoma Mimic Suspected: If Primary CNS Lymphoma is in the differential, caution clinicians that high-dose Dexamethasone can cause rapid tumor lysis ('ghost tumor'), rendering diagnostic stereotactic biopsy non-diagnostic.
  • 3.
    Functional Neuronavigation MRI Protocol: Perform volumetric 3D contrast-enhanced T1 (MPRAGE), DTI tractography (mapping corticospinal tracts and arcuate fasciculus), and functional MRI (fMRI for motor and language cortex) for neurosurgical navigation and maximal safe resection.
  • 4.
    Spine Staging for Drop Metastases: If ventricular entry or ependymal enhancement is noted, perform urgent whole-spine MRI with contrast to screen for CSF drop metastases.
  • 5.
    Neuro-Oncology MDT Presentation: Present to the Specialist Neuro-Oncology Multidisciplinary Team for planning maximal safe debulking surgery followed by Stupp Protocol (concomitant radiotherapy with Temozolomide [TMZ] chemotherapy) and molecular profiling (MGMT promoter methylation, IDH1/2 mutation status, and 1p/19q co-deletion).

Related Neuroradiology Reference Articles

Pleomorphic Adenoma (Benign Mixed Tumour)

Seen in middle-aged adults (peak age 30–60 years, 2:1 female predominance; accounts for 70–80% of all parotid gland tumours and is the most common salivary gland neoplasm overall), presenting with a painless, slow-growing, firm, mobile mass at the angle of the mandible or pre-auricular cheek. Caused by a benign biphasi

Read article →
Warthin Tumour (Papillary Cystadenoma Lymphomatosum)

Seen in older adults (peak age 50–70 years, strong male predominance, with >90% occurring in cigarette smokers; second most common benign parotid neoplasm), presenting with a painless, slow-growing, soft or fluctuant mass classically in the inferior pole (tail) of the parotid gland. Caused by heterotopic salivary ducta

Read article →
Pituitary Macroadenoma (Sellar & Suprasellar Mass)

Seen in adults (peak age 30–60 years; accounts for 10–15% of all intracranial neoplasms and is the most common sellar/suprasellar mass in adults), presenting with bitemporal hemianopia (from superior compression of the optic chiasm), hypopituitarism, hyperprolactinaemia ('stalk effect' or prolactinoma), or acute thunde

Read article →
Craniopharyngioma (Adamantinomatous & Papillary)

Seen in a classic bimodal age distribution—the primary peak in children aged 5–15 years (most common pediatricnonglial suprasellar neoplasm) and a second peak in adults aged 50–70 years—presenting with visual field defects (bitemporal hemianopia), growth failure/short stature, diabetes insipidus, and obstructive hydroc

Read article →